What is PyrAmes?
PyrAmes is a development-stage digital health company dedicated to revolutionizing healthcare delivery. Established in 2016 and headquartered in California, the company has engineered an advanced sensor measurement platform. This technology offers accurate, wireless, and non-invasive continuous blood pressure monitoring, aiming to enhance patient care and streamline health management through digital solutions.
How much funding has PyrAmes raised?
PyrAmes has raised a total of $6M across 1 funding round:
Series A
$6M
Series A (2021): $6M with participation from Keystone Ventures, GSR Ventures, and XTX Ventures
Key Investors in PyrAmes
Keystone Ventures
Keystone Ventures is a venture capital firm that likely focuses on early-stage and growth-stage companies, potentially within the technology or healthcare sectors, given their participation in this funding round.
GSR Ventures
GSR Ventures is a venture capital firm known for investing in technology and innovation, likely seeking to support companies with disruptive potential in their respective markets.
XTX Ventures
XTX Ventures is an investment entity that participates in strategic funding rounds, indicating a focus on companies with strong growth prospects and innovative technologies.
What's next for PyrAmes?
With a major strategic investment bolstering its resources, PyrAmes is poised for significant scaling and further development of its innovative health technology. The enterprise-level funding suggests a focus on expanding market reach, refining the platform's capabilities, and potentially forging key partnerships within the healthcare ecosystem. This capital infusion is expected to accelerate PyrAmes's mission to transform health monitoring and delivery.
See full PyrAmes company page
